Diabetic ketoacidosis after initiation of sodium-glucose cotransporter inhibition under advanced hybrid closed-loop therapy in type 1 diabetes
Visser M, Mathieu C, Gillard P
Diabetes Technol Ther. Pub. online 14 February 2022
Leggi
Breaking news
Upload and Review of Insulin Pump and Glucose Sensor Data by Adults with Type 1 Diabetes: A Clinic Audit
Kong YW, Venkatesh N, Paldus B et al
Diabetes Technol Ther. Pub. online 15 February 2022
Leggi
Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes. The SURPASS-5 randomized clinical trial
Dahl D, Onishi Y, Norwood P, et al.
JAMA. 2022;327(6):534-545.
Leggi
Tirzepatide for patients with type 2 diabetes
Chipkin SR
JAMA. 2022;327(6):529-530.
Leggi
Comparative safety of sodium–glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors and sulfonylureas on the risk of diabetic ketoacidosis
Dawwas GK, Flory JH, Hennessy S et al.
Diabetes Care. 2022;dc212177
Leggi
Identifying suicidal risk in adolescents and young adults with type 1 diabetes: are depression screeners sufficient?
Moss AC, Robert AJ, Yi-Frazier JP, et al.
Diabetes Care. 2022;dc211553
Leggi
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Kadowaki T, Isendahl J, Khalid U, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00008-0.
Leggi
Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study
Raverdy V, Cohen RV, Caiazzo R, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00005-5
Leggi
Diet quality in association to lipidaemic profile in adults of families at high-risk for type 2 diabetes in Europe: The Feel4Diabetes study
Chairistanidou C, Karatzi K, Karaglani E, et al.
NMCD. Pub. online 8 February 2022
Leggi
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
Cousin E, Duncan BB, Stein C, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(21)00349-1
Leggi